T2 Condition 237 241 p53−
T3 Condition 230 241 HCT116 p53−
T4 Condition 501 509 diabetes
T5 Gene 615 629 AMPK activator
T6 Condition 1054 1055 −
T7 Condition 1049 1053 p53−
T8 Condition 214 219 tumor
T9 Condition 1624 1629 tumor
T10 Protein 972 977 AICAR
T11 Condition 105 140 colon cancer cell lines HCT116 p53+
T12 Condition 327 331 p53−
T13 Intervention 177 186 metformin
T14 Condition 332 348 − tumor sections
T17 Level 388 395 − cells
T18 Condition 49 54 tumor
T19 Level 1469 1476 − cells
T20 Protein 614 619  AMPK
T21 Level 1531 1559 toxic to p53-deficient cells
T23 Biomarker 464 473 Metformin
T24 Condition 240 241 −
T25 Condition 786 787 −
T26 Biomarker 1223 1232 Metformin
T27 Intervention 1189 1211 mitochondrial electron
T28 Condition 242 243 −
T29 Intervention 1409 1418 metformin
T30 Level 1125 1148 metformin-treated cells
T31 Condition 677 678 −
T32 Level 1353 1357 p53-
T33 Level 1223 1246 Metformin-treated cells
T34 Condition 1464 1468 p53−
T35 Protein 548 577 AMP-activated protein kinase 
T36 Intervention 1125 1134 metformin
T38 Condition 679 680 −
T40 Condition 681 686 tumor
T43 Organism 1643 1651 patients
T44 Condition 157 158 −
T45 Condition 1052 1053 −
T47 Intervention 36 45 metformin
T48 Condition 242 254 − xenografts
T50 Condition 679 686 − tumor
T51 Intervention 1506 1515 metformin
T52 Condition 783 787 p53−
T53 Intervention 1153 1162 metformin
T54 Condition 1025 1029 p53+
T55 Condition 776 787 HCT116 p53−
T56 Biomarker 999 1021 fatty acid β-oxidation
T57 Condition 159 160 −
T58 Condition 674 678 p53−
T59 Protein 600 605 AICAR
T60 Level 1540 1544 p53-
T62 Condition 388 389 −
T63 Organism 883 922 nontransformed mouse embryo fibroblasts
T64 Condition 330 331 −
T66 Intervention 281 290 metformin
T68 Level 1054 1060 − MEFs
T69 Condition 332 333 −
T70 Condition 147 158 HCT116 p53−
T71 Level 788 795 − cells
